No Data
Less Volume, More Premium: Post-Ozempic Economics Are Killing The Quantity Model
Intel To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Thursday
H.C. Wainwright Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Cuts Target Price to $70
Structure Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Express News | Structure Therapeutics Inc : H.c. Wainwright Cuts Target Price to $70 From $100
Goldman Sachs raises obesity drug market forecast: Oral GLP-1 enters mass market, projected to reach $114 billion by 2030
① Goldman Sachs forecasts that the global weight-loss drug market will reach USD 114 billion by 2030, an upward revision of 13% from last year’s estimate; ② The oral weight-loss drug segment has outperformed expectations and is projected to generate approximately USD 46 billion in revenue by 2030, accounting for 40% of the global obesity drug market.